These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1528521)

  • 1. Stimulus functions of caffeine in humans: relation to dependence potential.
    Heishman SJ; Henningfield JE
    Neurosci Biobehav Rev; 1992; 16(3):273-87. PubMed ID: 1528521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are we dependent upon coffee and caffeine? A review on human and animal data.
    Nehlig A
    Neurosci Biobehav Rev; 1999 Mar; 23(4):563-76. PubMed ID: 10073894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of dopamine in the behavioral effects of caffeine in animals and humans.
    Garrett BE; Griffiths RR
    Pharmacol Biochem Behav; 1997 Jul; 57(3):533-41. PubMed ID: 9218278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of caffeine and benzphetamine in amphetamine-trained volunteers.
    Chait LD; Johanson CE
    Psychopharmacology (Berl); 1988; 96(3):302-8. PubMed ID: 3146764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats.
    Solinas M; Ferré S; Antoniou K; Quarta D; Justinova Z; Hockemeyer J; Pappas LA; Segal PN; Wertheim C; Müller CE; Goldberg SR
    Psychopharmacology (Berl); 2005 May; 179(3):576-86. PubMed ID: 15696333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinforcing and subjective effects of caffeine in normal human volunteers.
    Stern KN; Chait LD; Johanson CE
    Psychopharmacology (Berl); 1989; 98(1):81-8. PubMed ID: 2498963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine: cognitive and physical performance enhancer or psychoactive drug?
    Cappelletti S; Piacentino D; Sani G; Aromatario M
    Curr Neuropharmacol; 2015 Jan; 13(1):71-88. PubMed ID: 26074744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is caffeine addictive? The most widely used psychoactive substance in the world affects same parts of the brain as cocaine].
    Daly JW; Holmén J; Fredholm BB
    Lakartidningen; 1998 Dec; 95(51-52):5878-83. PubMed ID: 9889511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine induces differential cross tolerance to the amphetamine-like discriminative stimulus effects of dopaminergic agonists.
    Jain R; Holtzman SG
    Brain Res Bull; 2005 May; 65(5):415-21. PubMed ID: 15833596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinforcing effects of caffeine in coffee and capsules.
    Griffiths RR; Bigelow GE; Liebson IA
    J Exp Anal Behav; 1989 Sep; 52(2):127-40. PubMed ID: 2794839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinforcing properties of caffeine: studies in humans and laboratory animals.
    Griffiths RR; Woodson PP
    Pharmacol Biochem Behav; 1988 Feb; 29(2):419-27. PubMed ID: 3283780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers.
    Sobel BF; Sigmon SC; Griffiths RR
    Neuropsychopharmacology; 2004 May; 29(5):991-1003. PubMed ID: 15010695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical importance of caffeine dependence and abuse.
    Ogawa N; Ueki H
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):263-8. PubMed ID: 17472594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine expectancy: instrument development in the Rasch measurement framework.
    Heinz AJ; Kassel JD; Smith EV
    Psychol Addict Behav; 2009 Sep; 23(3):500-11. PubMed ID: 19769434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of caffeine on nicotine's discriminative stimulus, subjective, and reinforcing effects.
    Perkins KA; Fonte C; Stolinski A; Blakesley-Ball R; Wilson AS
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):275-81. PubMed ID: 16366757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of nicotine, amphetamine and cocaine under a fixed-interval schedule of food reinforcement in rats chronically exposed to caffeine.
    Jaszyna M; Gasior M; Shoaib M; Yasar S; Goldberg SR
    Psychopharmacology (Berl); 1998 Dec; 140(3):257-71. PubMed ID: 9877005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of dependence potential of drugs in humans using multiple indices.
    Johanson CE; Kilgore K; Uhlenhuth EH
    Psychopharmacology (Berl); 1983; 81(2):144-9. PubMed ID: 6415745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral interaction between cocaine and caffeine: a drug discrimination analysis in rats.
    Harland RD; Gauvin DV; Michaelis RC; Carney JM; Seale TW; Holloway FA
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1017-23. PubMed ID: 2798526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.